Clinical Trial Update: Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the use of combination chemotherapy as first-line therapy for locally advanced or metastatic neuroendocrine tumors of the duodenum or p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Neuroendocrine Tumor
• Neuroendocrine Tumor
• Pancreatic Neuroendocrine Tumor

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Gastrointestinal Carcinoid Tumor, Islet Cell Tumor | Phase 2 | Status: COMPLETED